Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens - A major pitfall in the management of lung cancer patients

被引:178
作者
Pelosi, G
Rodriguez, J
Viale, G
Rosai, J
机构
[1] Ist Europeo Oncol, Div Patol & Med Lab, I-20141 Milan, Italy
[2] Univ Milan, Sch Med, Milan, Italy
[3] Natl Canc Inst, Dept Pathol, I-20133 Milan, Italy
关键词
carcinoid; small-cell carcinoma; lung; Ki-67;
D O I
10.1097/01.pas.0000149690.75462.29
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Seven patients with typical or atypical pulmonary carcinoid tumors overdiagnosed as small-cell carcinoma on bronchoscopic biopsies are described. Bronchial biopsies from 9 consecutive small-cell lung carcinoma patients were used as control group for histologic and immunohistochemical Studies (cytokeratins, chromogranin A. synaptophysin, Ki-67 [MIB-1], and TTF-1). The carcinoid tumors presented as either central or peripheral lesions composed of tumor cells with granular, sometimes coarse chromatin pattern, high levels of chromogranin A/synaptophysin immunoreactivity, and low (<20%) Ki-67 (MIB-1) labeling index. The tumor stroma contained thin-walled blood vessels. Small-cell carcinomas always showed central tumor location, finely dispersed nuclear chromatin, lower levels of chromogranin A/synaptophysin, and high (>50%) Ki-67 (MIB-1) labeling index. The stroma contained thick-walled blood vessels with glomeruloid configuration. Judging from this study, overdiagnosis of carcinoid tumor as small-cell carcinoma in small crushed bronchial biopsies remains a significant potential problem in a worldwide sample of hospital settings. Careful evaluation of hematoxylin and eosin sections remains the most important tool for the differential diagnosis, with evaluation of tumor cell proliferation by Ki-67 (MIB-1) labeling index emerging from our review as the most useful ancillary technique for the distinction.
引用
收藏
页码:179 / 187
页数:9
相关论文
共 81 条
[1]   Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors [J].
Agoff, SN ;
Lamps, LW ;
Philip, AT ;
Amin, MB ;
Schmidt, RA ;
True, LD ;
Folpe, AL .
MODERN PATHOLOGY, 2000, 13 (03) :238-242
[2]  
[Anonymous], 2002, ENDOCR PATHOL
[3]   Neuroendocrine lung tumors: Grade correlates with proliferation but not angiogenesis [J].
Arbiser, ZK ;
Arbiser, JL ;
Cohen, C ;
Gal, AA .
MODERN PATHOLOGY, 2001, 14 (12) :1195-1199
[4]   Significance of cytologic criteria in distinguishing small cell from non-small cell carcinoma of the lung [J].
Arora, VK ;
Singh, N ;
Chaturvedi, S ;
Bhatia, A .
ACTA CYTOLOGICA, 2003, 47 (02) :216-220
[5]  
ASLAN DL, 2004, MOD PATHOL S1, V17, P333
[6]   OAT-CELL CARCINOMA OF THE BRONCHUS [J].
AZZOPARDI, JG .
JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1959, 78 (02) :513-&
[7]   TUMOR SUPPRESSOR GENE-PRODUCTS, PROLIFERATION, AND DIFFERENTIATION MARKERS IN LUNG NEUROENDOCRINE NEOPLASMS [J].
BARBARESCHI, M ;
GIRLANDO, S ;
MAURI, FA ;
ARRIGONI, G ;
LAURINO, L ;
DALLAPALMA, P ;
DOGLIONI, C .
JOURNAL OF PATHOLOGY, 1992, 166 (04) :343-350
[8]  
BEAN DM, 1976, J OTOLARYNGOL, V5, P519
[9]  
Brambilla E, 1996, AM J PATHOL, V149, P1941
[10]  
Brambilla E, 2000, SEMIN DIAGN PATHOL, V17, P138